Vivani Medical Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
Vivani Medical, Inc. (Nasdaq: VANI) (“Vivani” or the “Company”), a biopharmaceutical company developing miniaturized, long-term drug implants, including lead product candidate NPM-119 for the treatment of patients with type 2 diab...
Source: marketscreener.com